Clearance Summary
Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System received FDA 510(k) clearance under submission number DEN170078, sponsored by Brainways , Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2018-08-17.
- Submission: DEN170078
- Applicant / Sponsor: Brainways , Ltd.
- Clearance pathway: Direct
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5802
- Decision date: 2018-08-17
Classification & Regulation
This clearance is catalogued under FDA product code QCI and 21 CFR 882.5802, within the Neurology review panel as a Class II device.